Bristol Myers Squibb (BMY) Non-Current Deferred Tax Liability (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Non-Current Deferred Tax Liability of $228 million in Q3 2026, up 1.3% from $225 million a year earlier and up 2.7% from the prior quarter.
Bristol Myers Squibb (BMY) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb reported Non-Current Deferred Tax Liability of $222 million, down 39.8% from FY2024.
- Annual Non-Current Deferred Tax Liability has a five-year compound annual growth rate of -47.2% (FY2020 to FY2025).
- Across earlier years, Non-Current Deferred Tax Liability came in at $369 million in FY2024 (+9.2%), $338 million in FY2023 (-84.4%), $2.17 billion in FY2022 (-51.9%) and $4.5 billion in FY2021 (-16.8%).
- The Q3 2026 figure is the highest quarterly Non-Current Deferred Tax Liability since Q2 2025.
- On a year-over-year basis, Non-Current Deferred Tax Liability rose in two of the last eight quarters, with an average decline of 24.3%.
- Peak year-over-year performance for Non-Current Deferred Tax Liability in the last five years was growth of 9.2% in Q4 2024, against a decline of 86.2% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $222 million (Q2 2026), $211 million (Q1 2026) and $222 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 228.00 Mn |
| Jun 30, 2026 | 222.00 Mn |
| Mar 31, 2026 | 211.00 Mn |
| Dec 31, 2025 | 222.00 Mn |
| Sep 30, 2025 | 225.00 Mn |
| Jun 30, 2025 | 247.00 Mn |
| Mar 31, 2025 | 276.00 Mn |
| Dec 31, 2024 | 369.00 Mn |
| Sep 30, 2024 | 430.00 Mn |
| Jun 30, 2024 | 461.00 Mn |
| Mar 31, 2024 | 442.00 Mn |
| Dec 31, 2023 | 338.00 Mn |
| Sep 30, 2023 | 399.00 Mn |
| Jun 30, 2023 | 751.00 Mn |
| Mar 31, 2023 | 1.57 Bn |
| Dec 31, 2022 | 2.17 Bn |
| Sep 30, 2022 | 2.88 Bn |
| Jun 30, 2022 | 3.03 Bn |
| Mar 31, 2022 | 3.81 Bn |
| Dec 31, 2021 | 4.50 Bn |
Bristol Myers Squibb Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();